EUFLEXXA 1% SODIUM HYALURONATE

Acid, Hyaluronic, Intraarticular

FDA Premarket Approval P010029 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the sterile sodium hyaluronate (naha) to be stored in sterile, disposable polyethylene bags for up to 48 hours prior to filling the syringes. The device, as modified, will be marketed under the trade name euflexxa and is indicated for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and simple analgesics, e. G. , acetaminophen.

DeviceEUFLEXXA 1% SODIUM HYALURONATE
Classification NameAcid, Hyaluronic, Intraarticular
Generic NameAcid, Hyaluronic, Intraarticular
ApplicantFERRING PHARMACEUTICALS, INC.
Date Received2008-05-02
Decision Date2009-07-01
PMAP010029
SupplementS007
Product CodeMOZ
Docket NumberPremarket Approval (PMA) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Links U.S. Food & Drug Administration   Follow FDA En Español Search FDA   Home Food Drugs Medical Devices Radia
Advisory CommitteeOrthopedic
Supplement Type135 Review Track For 30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address FERRING PHARMACEUTICALS, INC. 100 Interpace Parkway parsippany, NJ 07054

Supplemental Filings

Supplement NumberDateSupplement Type
P010029Original Filing
S030 2020-04-02 30-day Notice
S029 2019-12-09 30-day Notice
S028 2019-04-05 30-day Notice
S027 2018-08-22 Real-time Process
S026 2018-03-29 30-day Notice
S025 2017-06-20 Normal 180 Day Track No User Fee
S024 2015-04-23 30-day Notice
S023 2015-03-06 30-day Notice
S022 2015-02-09 30-day Notice
S021 2014-12-24 30-day Notice
S020 2014-04-28 30-day Notice
S019 2014-02-20 30-day Notice
S018 2013-11-13 30-day Notice
S017 2013-05-08 30-day Notice
S016 2013-01-15 30-day Notice
S015 2012-04-05 30-day Notice
S014 2012-03-05 30-day Notice
S013 2011-12-29 30-day Notice
S012 2011-03-02 30-day Notice
S011 2009-12-07 30-day Notice
S010 2009-11-17 135 Review Track For 30-day Notice
S009 2009-11-09 30-day Notice
S008 2009-03-30 Panel Track
S007 2008-05-02 135 Review Track For 30-day Notice
S006 2007-03-22 Real-time Process
S005
S004 2006-09-18 Real-time Process
S003
S002 2005-10-05 Normal 180 Day Track No User Fee
S001 2005-01-13 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
05060548950064 P010029 000
07640128544210 P010029 001
05060459970045 P010029 024

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.